SHINKEI
Natural health product licensed in Canada
- Licence holder
- Sato Pharmaceutical
- NPN or DIN-HM
- 80054953
- Status
- Active licence
- Licence date
- 20 October 2014
- Revision date
- 13 May 2019
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cnidium monnierie Source : Fruit | 40 mg | Not calculated |
| Rehmannia glutinosa Source : Tubercule | 40 mg | Not calculated |
| 1,2,3,5/4,6- hexahydroxycyclohexane Source : Zea mays (Whole) | 40 mg | Not calculated |
| 1,2,3,5/4,6- hexahydroxycyclohexane Source : Monophosphate d'inositol | 40 mg | Not calculated |
| Vitamine B12 Source : Cobamamide | 10 mcg | 30 µg |
| Vitamine B12 Source : aphanizomenon flos-aquae - whole | 10 mcg | 30 µg |
| Angelica acutiloba Source : Racine | 40 mg | Not calculated |
| Paeonia lactiflora Source : Racine | 44 mg | Not calculated |
Non-medicinal ingredients
Extrait de racine de Glycyrrhiza glabra (Réglisse), Dioxyde de titane, Fécule de pommes de terre, Cellulose microcristalline, Hydroxypropylcellulose, acacia, Carmellose calcium, Hydroxypropyl amidon, Charbon, Shellac, Succinate de d-alpha-tocophéryle, Talc, Cire de Carnauba, Silicate d'aluminium, Lactose monohydrate, Carbonate de calcium, Gélatine, Sucrose, Stéarate de magnésium, Amidon de maïs modifié
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Inositol and Vitamin B12 are factors in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80054953
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging